KBC Group NV Has $138.07 Million Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

KBC Group NV grew its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 32.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,535,107 shares of the company’s stock after buying an additional 378,233 shares during the quarter. KBC Group NV’s holdings in DocuSign were worth $138,067,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp raised its stake in DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company’s stock worth $333,604,000 after buying an additional 120,743 shares during the period. Geode Capital Management LLC increased its holdings in shares of DocuSign by 1.6% during the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock valued at $215,789,000 after acquiring an additional 53,554 shares in the last quarter. Clearbridge Investments LLC raised its position in shares of DocuSign by 4.1% during the second quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company’s stock worth $156,265,000 after purchasing an additional 115,616 shares during the period. Thrivent Financial for Lutherans lifted its holdings in shares of DocuSign by 5.2% in the 3rd quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock worth $141,398,000 after purchasing an additional 112,919 shares in the last quarter. Finally, FMR LLC grew its position in DocuSign by 16.8% in the 3rd quarter. FMR LLC now owns 2,192,885 shares of the company’s stock valued at $136,156,000 after purchasing an additional 315,073 shares during the period. Institutional investors own 77.64% of the company’s stock.

Insider Transactions at DocuSign

In other news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the sale, the director now owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. This represents a 6.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction on Friday, January 10th. The stock was sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares in the company, valued at approximately $13,712,088.78. The trade was a 6.24 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 693,537 shares of company stock valued at $66,575,817. 1.66% of the stock is currently owned by company insiders.

DocuSign Trading Up 1.2 %

DocuSign stock opened at $91.60 on Monday. The firm’s 50 day simple moving average is $89.76 and its 200 day simple moving average is $71.57. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The firm has a market capitalization of $18.51 billion, a PE ratio of 18.89, a price-to-earnings-growth ratio of 8.30 and a beta of 0.88.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DOCU. UBS Group lifted their price objective on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. JPMorgan Chase & Co. raised their target price on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Tuesday, December 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 target price (up previously from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Finally, Morgan Stanley raised their price objective on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.